Membrane Oxygenators

Membrane Oxygenators Market Outlook

The global membrane oxygenators market is projected to reach approximately USD 3.1 billion by 2035, with a compound annual growth rate (CAGR) of around 6.9% during the forecast period from 2025 to 2035. Factors contributing to this growth include the rising prevalence of cardiac and respiratory diseases, advancements in medical technologies, and an increasing number of surgical procedures requiring oxygenation support. The growing geriatric population, which is more susceptible to chronic diseases, is further driving the demand for efficient oxygen delivery systems in hospitals and critical care units. Furthermore, the increasing focus on improving patient outcomes through innovative medical devices is expected to bolster market expansion. As healthcare providers continue to prioritize advanced and efficient treatment options, the membrane oxygenators market is set for significant growth over the coming decade.

Growth Factor of the Market

Several growth factors are driving the membrane oxygenators market. Firstly, the rise in cardiovascular surgeries and procedures requiring cardiopulmonary bypass is significantly contributing to the demand for membrane oxygenators. A surge in the incidence of respiratory issues, especially post-COVID-19, is further amplifying the necessity for oxygenation devices in critical care settings. Additionally, technological advancements leading to the development of more efficient and safer oxygenators are attracting healthcare facilities to upgrade their equipment. The increasing awareness and adoption of extracorporeal membrane oxygenation (ECMO) systems for advanced life support in critically ill patients are also noteworthy factors contributing to market growth. Moreover, government initiatives and healthcare expenditure in developing countries are expected to enhance accessibility to advanced medical devices, fostering market expansion.

Key Highlights of the Market

• The global membrane oxygenators market is poised for significant growth, driven by an increasing prevalence of respiratory and cardiovascular diseases.
• Technological advancements in membrane oxygenator design and materials are enhancing patient safety and device efficiency.
• The growing number of surgical procedures across hospitals is expected to boost the demand for membrane oxygenators significantly.
• Emerging markets are witnessing increased healthcare investment, leading to greater accessibility for advanced medical equipment.
• Government initiatives aimed at improving healthcare infrastructure are further bolstering market growth in various regions.

By Product Type

Hollow Fiber Membrane Oxygenators:

Hollow fiber membrane oxygenators are among the most widely used devices in the market due to their high oxygenation efficiency and surface area. These devices utilize fine fibers to create a large surface area for gas exchange, allowing for effective oxygenation of blood during surgical procedures, particularly cardiac surgeries. Their compact design makes them suitable for various applications, including cardiopulmonary bypass and extracorporeal membrane oxygenation (ECMO). The hollow fiber technology provides excellent blood compatibility, reducing the risk of hemolysis and enhancing patient safety. As a result, this product type is expected to dominate the market, supported by ongoing innovations that improve performance and safety profiles.

Microporous Membrane Oxygenators:

Microporous membrane oxygenators are designed with a unique membrane structure that allows for efficient gas exchange while maintaining low resistance to blood flow. These devices are particularly beneficial in scenarios where minimal blood trauma is desired. They are becoming increasingly popular in applications such as intensive care units (ICUs) and neonatal intensive care units (NICUs), where patient safety and comfort are paramount. The growing demand for minimally invasive procedures and patient-centered care is expected to drive the adoption of microporous membrane oxygenators, making them a key segment in the market.

Capillary Membrane Oxygenators:

Capillary membrane oxygenators utilize a capillary structure that offers a substantial surface area for gas exchange, making them highly efficient in oxygen delivery. These oxygenators are typically used in advanced life support scenarios, including ECMO, where high-performance oxygenation is critical. The design of capillary membranes minimizes blood trauma, enhancing their suitability for use in vulnerable patient populations, such as neonates and those with compromised health. The increasing recognition of ECMO as a life-saving intervention is anticipated to bolster the demand for capillary membrane oxygenators, thereby contributing to the overall market growth.

Flat Sheet Membrane Oxygenators:

Flat sheet membrane oxygenators are characterized by their flat design that facilitates effective gas exchange. These devices are particularly advantageous for applications where space is limited, as their profile can be more easily integrated into existing medical systems. They are commonly used in various clinical settings, including cardiac surgeries and transplant procedures. The simplicity of the flat sheet design, combined with advancements in membrane technology, is likely to drive the adoption of flat sheet membrane oxygenators in the healthcare sector, especially in hospitals and surgical centers.

Rolled Sheet Membrane Oxygenators:

Rolled sheet membrane oxygenators provide a practical solution for gas exchange in medical settings due to their efficient design that maximizes surface area while minimizing blood volume requirements. This makes them particularly suitable for use in scenarios where space conservation is essential. Their effectiveness in providing respiratory support during surgeries and critical care enhances their appeal to healthcare providers. As the demand for efficient and versatile oxygenation solutions continues to grow, rolled sheet membrane oxygenators are expected to capture a significant share of the market, contributing to the overall expansion of the membrane oxygenators segment.

By Application

Cardiopulmonary Bypass:

Cardiopulmonary bypass is one of the primary applications for membrane oxygenators. During cardiac surgeries, these devices temporarily take over the function of the heart and lungs, allowing for uninterrupted blood flow and oxygenation. The rising prevalence of heart diseases and the increasing number of cardiac surgeries performed globally are fueling the demand for membrane oxygenators in this application. Furthermore, advancements in surgical techniques and technologies have enhanced the safety and efficacy of cardiopulmonary bypass procedures, further driving the need for high-quality membrane oxygenators.

Extracorporeal Membrane Oxygenation:

Extracorporeal membrane oxygenation (ECMO) is a complex intervention used for patients with severe respiratory or cardiac failure. In this application, membrane oxygenators are critical for oxygenating blood outside the body, providing temporary support while the underlying condition is treated. The increasing recognition of ECMO as a life-saving therapy in critical care settings is significantly contributing to the growth of this segment. As healthcare facilities invest more in advanced life support technologies and training, the demand for specialized membrane oxygenators designed for ECMO procedures is expected to rise.

Intensive Care Units:

Membrane oxygenators play a vital role in intensive care units (ICUs) for patients requiring respiratory support. In these settings, the need for precise oxygenation and ventilation management is paramount, especially for patients with severe respiratory distress. The increasing incidence of respiratory conditions, alongside the growing aging population, is driving the demand for effective oxygenation solutions in ICUs. Healthcare providers are increasingly adopting advanced membrane oxygenators to improve patient outcomes and reduce associated complications, thereby enhancing the growth prospects of this application segment.

Neonatal Intensive Care Units:

Neonatal intensive care units (NICUs) require specialized equipment to support the unique respiratory needs of newborns, particularly preterm infants who are at risk for respiratory complications. Membrane oxygenators designed for neonatal use are tailored to deliver precise oxygen levels while minimizing the risk of adverse effects. The rising number of premature births and the subsequent need for advanced neonatal care are propelling the demand for membrane oxygenators in NICUs. Continuous advancements in technology and a growing emphasis on improving neonatal outcomes are expected to drive growth in this application segment.

Others:

In addition to the primary applications mentioned, membrane oxygenators are utilized in various other medical scenarios, such as surgical procedures unrelated to cardiac care, organ transplantation, and research applications. This diverse range of applications presents significant opportunities for growth in the membrane oxygenators market. As healthcare providers seek innovative solutions to enhance patient care and address specific medical needs, the demand for specialized membrane oxygenators in these ancillary applications is likely to expand, contributing to the overall market growth.

By Distribution Channel

Hospitals:

Hospitals constitute the largest distribution channel for membrane oxygenators, as they are the primary sites for surgical procedures and critical care interventions. The increasing number of surgical operations and the growing prevalence of chronic diseases necessitate the availability of advanced medical devices, including membrane oxygenators, within hospital settings. The trend towards improving healthcare infrastructure and the adoption of technological advancements in hospitals further enhance the demand for these devices. As hospitals continue to prioritize patient safety and treatment efficacy, the reliance on membrane oxygenators for various applications will remain strong, bolstering this distribution channel.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as a significant distribution channel for membrane oxygenators, particularly for outpatient procedures that require oxygenation support. The growing trend toward minimally invasive surgeries and the increasing preference for outpatient care are driving the adoption of membrane oxygenators in these settings. ASCs often seek to optimize their operational efficiency and patient outcomes, prompting them to invest in advanced medical devices. As the volume of outpatient surgeries continues to rise, the demand for membrane oxygenators within ASCs is expected to grow correspondingly, further expanding this distribution channel.

Specialty Clinics:

Specialty clinics that focus on specific medical fields, such as cardiology and pulmonology, are becoming increasingly relevant as distribution channels for membrane oxygenators. These clinics often require specialized equipment to provide targeted care for patients with specific conditions. The demand for effective oxygenation solutions in these settings is rising, driven by the growing awareness of chronic diseases and the need for specialized interventions. As more specialty clinics emerge and expand their offerings, the market for membrane oxygenators through this distribution channel is anticipated to witness significant growth.

Online Stores:

The rise of e-commerce has also impacted the distribution of medical devices, including membrane oxygenators. Online stores offer a convenient platform for healthcare facilities and providers to procure essential medical equipment, including oxygenators. The increasing adoption of digital platforms for purchasing medical supplies is driven by the need for efficiency and the desire for competitive pricing. As healthcare providers become more comfortable with online transactions and the availability of a wider variety of products, the demand for membrane oxygenators through online stores is expected to grow, reflecting a changing landscape in the distribution of medical devices.

Others:

Other distribution channels for membrane oxygenators include medical device distributors and wholesalers, which play a crucial role in ensuring that healthcare providers have timely access to necessary equipment. The importance of maintaining a robust supply chain for medical devices, especially during times of increased demand, cannot be overstated. Additionally, direct sales from manufacturers to healthcare facilities are also gaining traction as hospitals seek more streamlined purchasing processes. As healthcare providers look for reliable sources for their medical equipment needs, the presence of diverse distribution channels will continue to support the growth of the membrane oxygenators market.

By Material Type

Silicone Membrane Oxygenators:

Silicone membrane oxygenators are increasingly being utilized due to their excellent biocompatibility and oxygen transfer characteristics. The silicone material provides flexibility and durability, making these oxygenators ideal for long-term use in various medical applications, including ECMO and cardiopulmonary bypass. The growing focus on patient safety and the reduction of adverse reactions during procedures are driving the demand for silicone-based products. As healthcare providers prioritize high-quality materials that enhance patient outcomes, silicone membrane oxygenators are expected to witness significant growth in the market.

Polypropylene Membrane Oxygenators:

Polypropylene membrane oxygenators are favored for their strength and chemical resistance, making them suitable for a wide range of applications. This material offers excellent oxygenation efficiency while minimizing the risk of hemolysis, a critical factor when dealing with blood products. The increasing use of polypropylene membranes in advanced medical devices is enhancing their appeal among healthcare providers. As more hospitals and clinics adopt polypropylene membrane oxygenators for surgical procedures and critical care, this segment is likely to witness substantial growth in the coming years.

Polysulfone Membrane Oxygenators:

Polysulfone membrane oxygenators are known for their superior performance in gas exchange processes, making them a popular choice in various medical applications. The inherent properties of polysulfone, such as thermal stability and resistance to fouling, contribute to the durability and efficiency of these oxygenators. As healthcare providers seek reliable and effective solutions for oxygenation, polysulfone membrane oxygenators are projected to gain significant traction in the market. The continuous advancements in polysulfone technology are expected to further boost their adoption rates across diverse medical settings.

Polyethylene Membrane Oxygenators:

Polyethylene membrane oxygenators provide a balance of cost-effectiveness and efficiency, making them suitable for a variety of applications in healthcare. This material offers good gas permeability and biocompatibility, essential for ensuring patient safety during procedures. The demand for polyethylene-based oxygenators is likely to rise as more facilities look for economically viable yet effective solutions for oxygenation. As the healthcare industry increasingly emphasizes cost-effective solutions without compromising quality, polyethylene membrane oxygenators are expected to capture a notable share of the market.

Others:

In addition to the primary material types mentioned, other materials are also being explored for membrane oxygenators, including advanced composite materials that aim to enhance performance while reducing weight. Research and development initiatives are focusing on creating novel materials that improve oxygen transfer rates and blood compatibility. The exploration of alternative materials is indicative of the ongoing efforts within the industry to innovate and provide superior products. As the demand for cutting-edge medical devices continues to grow, the segment representing other material types in the membrane oxygenators market is likely to expand, providing promising opportunities for manufacturers.

By Region

The membrane oxygenators market is witnessing robust growth across various regions, with North America leading the charge. The region accounted for approximately 35% of the global market share in 2023, driven by the presence of advanced healthcare infrastructure, increasing surgical volumes, and a high prevalence of chronic diseases. Additionally, North America is characterized by a strong emphasis on research and development, leading to continuous technological advancements in medical devices. The CAGR for the North American market is projected to be around 7.5% between 2025 and 2035, highlighting the region's potential for sustainable growth as healthcare providers increasingly adopt state-of-the-art membrane oxygenators.

Europe is also emerging as a significant market for membrane oxygenators, holding an estimated share of 30% in 2023. This region is characterized by a well-established healthcare system, rising investments in healthcare technologies, and an increasing number of surgical procedures. The growing geriatric population, particularly in countries like Germany and France, is further propelling the demand for advanced medical devices, including membrane oxygenators. The projected CAGR for the European market is around 6.8%, reflecting a steady growth trajectory as healthcare providers prioritize improved patient outcomes through technology adoption. Other regions, including Asia Pacific, Latin America, and the Middle East & Africa, also showcase potential for growth, albeit at varying rates based on local healthcare development and economic conditions.

Opportunities

The membrane oxygenators market presents numerous opportunities for growth, particularly in emerging economies where healthcare infrastructure is rapidly evolving. As governments invest significantly in healthcare development, the demand for advanced medical devices, including membrane oxygenators, is poised to rise. The increasing prevalence of chronic diseases, driven by lifestyle changes and an aging population, creates an urgent need for effective oxygenation solutions in hospitals and healthcare facilities. Moreover, the ongoing advancements in technology, such as the development of more efficient and biocompatible membranes, are expected to enhance the performance of membrane oxygenators, creating further opportunities for manufacturers to innovate and expand their product offerings.

Another significant opportunity lies in the growing trend of outpatient services and minimally invasive surgeries, which are redefining the landscape of healthcare delivery. As more patients opt for surgeries that do not require prolonged hospital stays, the demand for portable and efficient oxygenation systems is expected to rise. Companies that can develop compact and user-friendly membrane oxygenators are likely to gain a competitive edge in this changing market. Furthermore, collaborations between manufacturers and healthcare providers can lead to tailored solutions that meet specific clinical needs, opening new avenues for growth and expanding market reach.

Threats

The membrane oxygenators market faces several threats that could impede its growth trajectory. One of the primary concerns is the stringent regulatory environment surrounding medical devices, which can lead to increased costs and longer timeframes for product development and approval. Manufacturers must navigate complex compliance requirements, which can hinder innovation and market entry, particularly for smaller firms. Additionally, the increasing competition in the medical device industry poses a challenge, as numerous players strive to capture market share by offering similar products at competitive prices. This heightened competition may lead to price wars, further squeezing profit margins for manufacturers.

Another significant threat is the potential for product recalls or adverse events associated with membrane oxygenators, which can damage a company's reputation and lead to legal repercussions. The healthcare industry is highly sensitive to any negative publicity, and manufacturers must prioritize quality control and risk management to mitigate such threats. Furthermore, the ongoing global supply chain disruptions, exacerbated by geopolitical tensions and the COVID-19 pandemic, may affect the availability of raw materials and components necessary for the production of membrane oxygenators, posing challenges to meeting market demand efficiently.

Competitor Outlook

• Medtronic plc
• Terumo Corporation
• Getinge AB
• Fresenius Medical Care AG & Co. KGaA
• Gambro Lundia AB
• Maquet Holding B.V. & Co. KG
• Jiangsu Wuxi Huadong Medical Company Limited
• Sorin Group Italia S.r.l.
• MicroPort Scientific Corporation
• Zoll Medical Corporation
• Nipro Corporation
• Asahi Kasei Corporation
• Medos Medizintechnik AG
• Alung Technologies, Inc.
• CardioMed, Inc.

The competitive landscape of the membrane oxygenators market is characterized by the presence of several prominent players who are engaged in continuous innovation and strategic partnerships. Major companies such as Medtronic, Terumo Corporation, and Getinge AB dominate the market, leveraging their established reputations and extensive product portfolios. These companies are investing heavily in research and development to enhance their product offerings and stay ahead of emerging trends in the healthcare sector. Additionally, collaborations and mergers are common strategies employed by these organizations to expand their market reach and improve operational efficiencies.

Medtronic plc, a global leader in medical technology, is known for its comprehensive range of membrane oxygenators used in various cardiac and respiratory applications. The company’s emphasis on innovation and patient safety drives its product development strategies, which focus on creating advanced oxygenation systems tailored to meet specific clinical needs. Furthermore, Terumo Corporation, renowned for its expertise in blood management technologies, is also a key player in the membrane oxygenators market, continuously expanding its offerings to include state-of-the-art devices that enhance patient care and outcomes.

Another notable player, Getinge AB, is recognized for its commitment to providing high-quality medical devices, including membrane oxygenators for cardiopulmonary bypass and ECMO. The company's focus on research and development has led to the introduction of novel technologies that improve the efficiency and safety of oxygenation solutions. With an emphasis on sustainable healthcare practices, Getinge is likely to make significant strides in addressing the evolving needs of the healthcare industry, further solidifying its presence in the membrane oxygenators market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Getinge AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 CardioMed, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Gambro Lundia AB
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Nipro Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Terumo Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Asahi Kasei Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Medos Medizintechnik AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Alung Technologies, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Zoll Medical Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Sorin Group Italia S.r.l.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Maquet Holding B.V. & Co. KG
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 MicroPort Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fresenius Medical Care AG & Co. KGaA
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Jiangsu Wuxi Huadong Medical Company Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Membrane Oxygenators Market, By Application
    • 6.1.1 Cardiopulmonary Bypass
    • 6.1.2 Extracorporeal Membrane Oxygenation
    • 6.1.3 Intensive Care Units
    • 6.1.4 Neonatal Intensive Care Units
    • 6.1.5 Others
  • 6.2 Membrane Oxygenators Market, By Product Type
    • 6.2.1 Hollow Fiber Membrane Oxygenators
    • 6.2.2 Microporous Membrane Oxygenators
    • 6.2.3 Capillary Membrane Oxygenators
    • 6.2.4 Flat Sheet Membrane Oxygenators
    • 6.2.5 Rolled Sheet Membrane Oxygenators
  • 6.3 Membrane Oxygenators Market, By Material Type
    • 6.3.1 Silicone Membrane Oxygenators
    • 6.3.2 Polypropylene Membrane Oxygenators
    • 6.3.3 Polysulfone Membrane Oxygenators
    • 6.3.4 Polyethylene Membrane Oxygenators
    • 6.3.5 Others
  • 6.4 Membrane Oxygenators Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Online Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Membrane Oxygenators Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Membrane Oxygenators market is categorized based on

By Product Type

• Hollow Fiber Membrane Oxygenators
• Microporous Membrane Oxygenators
• Capillary Membrane Oxygenators
• Flat Sheet Membrane Oxygenators
• Rolled Sheet Membrane Oxygenators

By Application

• Cardiopulmonary Bypass
• Extracorporeal Membrane Oxygenation
• Intensive Care Units
• Neonatal Intensive Care Units
• Others

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Online Stores
• Others

By Material Type

• Silicone Membrane Oxygenators
• Polypropylene Membrane Oxygenators
• Polysulfone Membrane Oxygenators
• Polyethylene Membrane Oxygenators
• Others

By Region

• Asia Pacific
• North America
• Latin America
• Europe
• Middle East & Africa

Key Players

• Medtronic plc
• Terumo Corporation
• Getinge AB
• Fresenius Medical Care AG & Co. KGaA
• Gambro Lundia AB
• Maquet Holding B.V. & Co. KG
• Jiangsu Wuxi Huadong Medical Company Limited
• Sorin Group Italia S.r.l.
• MicroPort Scientific Corporation
• Zoll Medical Corporation
• Nipro Corporation
• Asahi Kasei Corporation
• Medos Medizintechnik AG
• Alung Technologies, Inc.
• CardioMed, Inc.